Vasculitis Trial, Recruiting NCT06279065 Sponsor: University of Bonn Condition: Vasculitis
Back to Vasculitis

Vasculitis Trial, Recruiting

NCT06279065
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Giant cell arteritis (this applies to one specific group within the trial)

Who may not be able to join:

  • You have a long-term (chronic) infection, such as a viral, fungal, or bacterial infection, including HIV or Hepatitis B or C
  • You have had an acute (sudden/short-term) infection and took antibiotics within the last 90 days before joining the trial
  • You have had major surgery on your stomach or intestines (digestive system) within the last 5 years
  • You have had bleeding in your stomach or intestines within the last 90 days
  • You have been diagnosed with inflammatory bowel disease that has been confirmed by a tissue biopsy (a small sample taken and examined in a lab)
  • You have been diagnosed with bulimia or anorexia nervosa (eating disorders)
  • Your body mass index (BMI — a measure of body weight relative to height) is 40 or above
  • You have taken high-dose probiotic supplements (more than 1 billion live cultures per day) within the last 90 days
  • You have diabetes that is not well controlled
  • You have been diagnosed with cancer within the last year (confirm with trial site for specific exceptions mentioned in the criteria)
  • You have a known problem with alcohol or drug misuse

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Bonn
Registry
ClinicalTrials.gov
Start date
29 February 2024
Est. completion
18 February 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Significant differences in the composition of the microbiome

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov